Clearmind Medicine Expands Clinical Trials with Key Partnership
Clearmind Medicine Inc. (NASDAQ: CMND), a forward-thinking biotech company, has taken a significant step in its mission to tackle Alcohol Use Disorder (AUD) through the expansion of its clinical trial network. The company has recently partnered with the Tel Aviv Sourasky Medical Center, adding this esteemed institution as a new clinical site for its ongoing Phase I/IIa clinical trial of CMND-100, a promising oral drug candidate based on the MEAI compound.
New Site Strengthening the Clinical Network
The addition of the Tel Aviv Sourasky Medical Center to Clearmind's trial represents a major milestone. It follows the announcement of the enrollment of the first patient, marking exciting progress for the team. This cultural and scientific hub is known for its commitment to medical innovation, making it a fitting partner for Clearmind's clinical endeavors. With Dr. David Zeltser at the helm, the facility is set to play an integral role in the rigorous evaluation of CMND-100.
Enhancing Research Capabilities
CMND-100 is being developed to address the pressing issue of AUD, which impacts millions worldwide. The trial aims to assess not only the safety and tolerability of the drug but also its efficacy in reducing alcohol cravings and consumption among patients. Clearmind's collaboration with Tel Aviv Sourasky Medical Center, alongside prominent institutions like Yale and Johns Hopkins University, significantly enhances its capabilities to conduct comprehensive research.
CEO's Vision for Expansion
Dr. Adi Zuloff-Shani, CEO of Clearmind, expressed enthusiasm regarding this latest collaboration, stating it reinforces their commitment to pioneering solutions for AUD. The CEO noted how this expansion symbolizes a proactive approach in tackling the global health crisis this disorder represents. Dr. Zuloff-Shani emphasized that with research evolving at such a rapid pace, forming alliances with reputable clinical sites is essential.
Commitment to Addressing Global Health Issues
The World Health Organization reports that AUD is responsible for approximately 2.6 million deaths annually, underscoring the urgency of finding effective treatments. Clearmind’s dedication can be seen not only through its innovative drug development but also in its strategic partnerships that aim to expand healthcare access and alternatives for those affected by AUD.
About Clearmind Medicine Inc.
Clearmind is at the groundbreaking frontier of developing psychedelic-based therapeutics aimed at a range of health issues previously deemed under-researched. With a commitment to integrity and innovation, the company is heavily invested in building a diverse portfolio of intellectual property, currently housing an impressive 31 granted patents across nineteen families.
Future Plans and Aspirations
The firm is actively advancing its efforts to secure additional patents and explore new avenues for commercializing its compounds. This strategy not only fortifies Clearmind's market position but also enhances its potential to bring novel therapeutic solutions to those who need them most.
Contact Information
For more details about Clearmind Medicine, potential investors and interested parties can contact the company directly. General inquiries can be directed to info@clearmindmedicine.com. Alternatively, individuals can reach out via telephone at (604) 260-1566.
Frequently Asked Questions
What is CMND-100?
CMND-100 is an oral drug candidate developed by Clearmind Medicine for treating Alcohol Use Disorder (AUD).
Who is involved in the clinical trial?
The trial includes partnerships with Tel Aviv Sourasky Medical Center, Yale School of Medicine, and Johns Hopkins University.
Why is this clinical trial significant?
This clinical trial seeks to evaluate the safety and effectiveness of CMND-100, which could potentially reduce alcohol cravings and consumption.
How is Clearmind Medicine addressing AUD?
Clearmind Medicine focuses on discovering innovative therapeutic solutions to treat AUD and its associated health complications.
How can I contact Clearmind Medicine for more information?
You can reach out via email at invest@clearmindmedicine.com or through their official website.
